Characteristics | Â | Female | Male | Total |
---|---|---|---|---|
 |  | N = 66 (28.3%) | N = 167 (71.7%) | N = 233 (100%) |
Median age at enrollment (N = 232/1 missing data) | Median [IQR] | 31 [26–45] | 40 [32–47] | 37 [30–45] |
Median age at the time of TB diagnosis, years (N = 251/1 missing data) | Median [IQR] | 32 [28–39] | 40 [32–48] | 37 [31–45] |
Region of origin (N = 223/10 missing data) | N. (%) |  |  |  |
   Germany |  | 8 (12.5) | 81 (50.9) | 89 (39.9) |
   Sub-Saharan Africa |  | 41 (64.1) | 41 (25.8) | 82 (36.8) |
   Other countries |  | 15 (23.4) | 37 (23.3) | 52 (23.3) |
HIV-transmission risk group (N = 214/19 missing data) | N. (%) |  |  |  |
   MSM |  | --- | 67 (43.8) | 67 (31.3) |
   PWID |  | 3 (4.9) | 17 (11.1) | 20 (9.4) |
   HPC |  | 54 (88.5) | 43 (28.1) | 97 (45.3) |
   Others†|  | 4 (6.6) | 26 (16.9) | 30 (14.0) |
Median CD4+ blood cell count at enrollment (N = 221/12 missing data) | Median [IQR] | 197 [67–349] | 204 [67–375] | 189 [66–348] |
Median CD4+ blood cell count at the time of TB diagnosis (N = 194/39 missing data) | Median [IQR] | 211 [65–339] | 198 [47–339] | 216 [69–350] |
Median viral load at enrollment (log10copies/ml) (N = 210/23 missing data) | Median [IQR] | 4.8 [3.6-5.4] | 4.7 [3.4-5.5] | 4.9 [3.6-5.3] |
Median viral load at the time of TB diagnosis (N = 145/88 missing data) | Median [IQR] | 5.0 [4.3-5.6] | 5.2 [4.5-5.7] | 5.9 [3.9-5.5] |
Hepatitis B* (N = 233) | Median [IQR] | 25 (37.9) | 39 (23.4) | 64 (27.5) |
Hepatitis C* (N = 233) | Median [IQR] | 5 (7.6) | 18 (10.8) | 23 (9.9) |
Diabetes mellitus* (N = 233) | Median [IQR] | 2 (3.0) | 5 (3.0) | 7 (3.0) |
cART‡ (N = 233) | Median [IQR] | 31 (50.0) | 99 (59.3) | 130 (55.8) |
Died (N = 233) | N. (%) | 4 (10.6) | 18 (10.8) | 25 (10.7) |